Evaluation of Osteopathic Care After Rupture of the Antero-external Cruciate Ligament of the Knee (DIDT OSTEO)

NCT ID: NCT05875766

Last Updated: 2023-05-25

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

94 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-04-07

Study Completion Date

2024-12-07

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The antero-external cruciate ligament (ACL) is the ligament located inside the knee, which allows the rotation of the knee by stabilizing the femur and the tibia. Rupture of the ACL is common during the practice of certain so-called "pivot" sports, whether contact or not. It is manifested by acute pain or instability of the knee, following a crack during a twist and/or a blockage of the joint. The diagnosis will be confirmed by a clinical examination and X-rays to eliminate any fracture or tearing and by MRI to visualize the ligament rupture and the associated lesions, in particular a lesion of the meniscus.

Treatment is required because the ruptured ligament does not heal on its own and the rupture of the ligament may eventually promote the appearance of osteoarthritis. Two types of treatment can be considered, rehabilitation or surgery, depending on the patient's age and motivation to resume sports. There are several surgical techniques, the most common is to reconstruct the ruptured ligament by arthroscopy using a graft taken from the tendons of the Internal Rectus and Demi muscles tendinous (DIDT). Rehabilitation by physiotherapy is often started preoperatively and immediately after the operation, as soon as you wake up, to find a functional and painless knee. Functional recovery often depends on patient motivation.

The main objective is to show that osteopathic care in addition to physiotherapy rehabilitation improves knee functionality in patients 6 months after reconstruction of the ACL by DIDT.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cruciate Ligament Rupture Knee Ligament Injury Osteopathia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Patient with osteopathy session

Patients after their DIDT surgery have 4 osteopathy sessions in addition to physiotherapy

Group Type EXPERIMENTAL

Osteopathy

Intervention Type OTHER

4 sessions of osteopathy after DIDT surgery

Physiotherapy

Intervention Type OTHER

Physiotherapy after DIDT surgery (reference treatment)

Patient without osteopathy session

Patients after their DIDT surgery have only physiotherapy

Group Type PLACEBO_COMPARATOR

Physiotherapy

Intervention Type OTHER

Physiotherapy after DIDT surgery (reference treatment)

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Osteopathy

4 sessions of osteopathy after DIDT surgery

Intervention Type OTHER

Physiotherapy

Physiotherapy after DIDT surgery (reference treatment)

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patient, male or female, aged 18 to 35 inclusive
* Patient with a BMI between 18.5 and 30 kg/m² (limits included).
* Patient presenting with a total rupture of the unilateral anterior cruciate ligament (ACL).
* Candidate patient for reconstruction of the ACL with the DIDT method.
* Affiliated patient or beneficiary of a social security scheme.
* Patient having been informed and having given their free consent, enlightened and written.

Exclusion Criteria

* Patient with damage to another structure of the knee, other than meniscal lesions.
* Patient with a contraindication to osteopathic intervention.
* Patient for whom a method other than DIDT has been proposed.
* Patient with iterative rupture of the ACL.
* Patient having undergone ligamentoplasty of the contralateral knee
* Patient participating in another research.
* Patient in period of exclusion from another research still in progress at the time of inclusion.
* Protected patient: adult under guardianship, curatorship or other legal protection, deprived of liberty by judicial or administrative decision.
* Pregnant, breastfeeding or parturient women.
* Patient hospitalized without consent.
Minimum Eligible Age

18 Years

Maximum Eligible Age

35 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Ramsay Générale de Santé

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Hopital privé Jean Mermoz

Lyon, , France

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

France

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Jean-François Oudet

Role: CONTACT

0683346567

Marie Hélène Barba

Role: CONTACT

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Nicolas CHOPIN, Dr

Role: primary

06 11 29 07 26

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2022-A00450-43

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.